The global coagulation analyzer market is anticipated to grow at a considerable CAGR of 9.5% during the forecast period (2022-2028). The market growth is being driven by the presence of prominent players contributing towards the growth of the market. The key companies operating in coagulation analyzer market are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact the market growth. For instance, in May 2021, HORIBA Medical has upgraded its Yumizen G800 hemostasis analyzer with more pre-analytical functionality by introducing the latest software version 2.36. This new software recognizes that pre-analytical conditions are critical in hemostasis and generate up to 70% results and also helps in overcoming a significant pre-analytical error risk factor and also integrates an optional automatic check of tube filling.
Browse the full report description of “Global Coagulation Analyzer Market Size, Share, and Trends Analysis Report by Product (Semi-Automated Coagulation Analyzers, and Manual Coagulation Analyzer), by Test Type (Fibrinogen Testing, D-Dimer Testing, Platelet Function Tests, and Other), by Technology (Optical , Mechanical , Electrochemical , and Others) and by End-User (Hospitals, Diagnostic Centers, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/coagulation-analyzer-market
In addition, in February 2021, Siemens Healthineers and Sysmex Corp., both the companies upgraded their broad portfolio of hemostasis products and provide one of the largest portfolios of hemostasis testing systems and reagents that are fulfilling laboratories' diverse needs. Moreover, through this agreement, Siemens Healthineers will distribute the new Sysmex CN Systems series automated blood coagulation analyzers and the CN-3000 and CN-6000, by Siemens Healthineers that offer mid- and high-volume coagulation testing to laboratories.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Test Type
o By Technology
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- ACON Laboratories, Inc., Fisher Scientific Co. L.L.C., F. Hoffmann-La Roche Ltd., Helena Laboratories Corp., Meril Life Sciences Pvt. Ltd. Siemens Healthcare GmbH, Trivitron Healthcare, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Coagulation Analyzer Market Report Segment
By Product
By Test Type
By Technology
By End-User
Global Coagulation Analyzer Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/coagulation-analyzer-market